Cours Quest PharmaTech Inc. Other OTC
Actions
QPTFF
CA74836M1068
Recherche biotechnologique et médicale
CA 2023 | - | CA 2024 | - | Capitalisation | 4,23 M 3,78 M |
---|---|---|---|---|---|
Résultat net 2023 | -7 M -6,27 M | Résultat net 2024 | -3 M -2,69 M | VE / CA 2023 | - |
Dette nette 2023 | 625 k 560 k | Dette nette 2024 | 283 k 253 k | VE / CA 2024 | - |
PER 2023 |
-1,61
x | PER 2024 |
-1,4
x | Employés | - |
Rendement 2023 * |
-
| Rendement 2024 |
-
| Flottant | 82,88% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | - | 17/06/04 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/05 |
Eliel Bayever
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | - | 17/06/04 | |
J. Lievonen
CHM | Chairman | - | 05/07/21 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+38,36% | 52,73 Md | |
+36,73% | 39 Md | |
-8,63% | 38,52 Md | |
+25,46% | 30,38 Md | |
-11,17% | 26,39 Md | |
+11,44% | 26,08 Md | |
+45,09% | 14,15 Md | |
+32,93% | 12,6 Md | |
-5,30% | 11,51 Md |